Cargando…

Current state of evidence of cannabis utilization for treatment of autism spectrum disorders

The core symptoms and co-morbidities associated with autism spectrum disorders (ASD) affect daily living and quality of life. Existing pharmacological interventions are only able to attenuate some related symptoms but are unable to address the underlying etiologies associated with ASD. Anecdotal evi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Agarwal, Rumi, Burke, Shanna L., Maddux, Marlaina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Debate
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819459/ https://www.ncbi.nlm.nih.gov/pubmed/31664964 http://dx.doi.org/10.1186/s12888-019-2259-4

Ejemplares similares

How Robust is the Evidence for a Role of Oxidative Stress in Autism Spectrum Disorders and Intellectual Disabilities?
por: Burke, Shanna L., et al.
Publicado: (2020)

Utilization of Complementary and Alternative Therapies in Youth with Developmental Disabilities
por: Tenenbaum, Rachel, et al.
Publicado: (2019)

A debate on current eating disorder diagnoses in light of neurobiological findings: is it time for a spectrum model?
por: Brooks, Samantha Jane, et al.
Publicado: (2012)

Stress and Anxiety Among Parents of Transition-Aged Children with Autism Spectrum Disorder: a Systematic Review of Interventions and Scales
por: Agarwal, Rumi, et al.
Publicado: (2022)

Guidelines for the pharmacological acute treatment of major depression: conflicts with current evidence as demonstrated with the German S3-guidelines
por: Plöderl, Martin, et al.
Publicado: (2019)

Safety and Efficacy of Cannabis in Autism Spectrum Disorder
por: Ganesh, Abhinaya, et al.
Publicado: (2020)

Children with autism spectrum disorders and severe visual impairments: Some general principles for intervention according to the perspective of clinical psychology of disability
por: Petretto, Donatella Rita, et al.
Publicado: (2023)

Implementation support practitioners – a proposal for consolidating a diverse evidence base
por: Albers, Bianca, et al.
Publicado: (2020)

Assessing competency in Evidence Based Practice: strengths and limitations of current tools in practice
por: Ilic, Dragan
Publicado: (2009)

Hypersplenism in liver disease and SLE revisited: current evidence supports an active rather than passive process
por: Gemery, John M., et al.
Publicado: (2016)

Mental disorders as risk factors: assessing the evidence for the Global Burden of Disease Study
por: Baxter, Amanda J, et al.
Publicado: (2011)

Giant cell arteritis: is the clinical spectrum of the disease changing?
por: González-Gay, Miguel Á., et al.
Publicado: (2019)

Genetics and epigenetics of autism spectrum disorder—current evidence in the field
por: Wiśniowiecka-Kowalnik, Barbara, et al.
Publicado: (2019)

Self-reported and routinely collected electronic healthcare resource-use data for trial-based economic evaluations: the current state of play in England and considerations for the future
por: Franklin, Matthew, et al.
Publicado: (2019)

Cannabis and cannabinoid use in autism spectrum disorder: a systematic review
por: da Silva, Estácio Amaro, et al.
Publicado: (2021)

Defining & assessing the quality, usability, and utilization of immunization data
por: Bloland, Peter, et al.
Publicado: (2019)

Does directly observed therapy improve tuberculosis treatment? More evidence is needed to guide tuberculosis policy
por: McLaren, Zoë M., et al.
Publicado: (2016)

“The post-COVID era”: challenges in the treatment of substance use disorder (SUD) after the pandemic
por: López-Pelayo, Hugo, et al.
Publicado: (2020)

Legal cannabis—what's in it?
por: Cousijn, Janna
Publicado: (2020)

Microglia and Autism Spectrum Disorder: Overview of Current Evidence and Novel Immunomodulatory Treatment Options
por: Kim, Jung Won, et al.
Publicado: (2018)

Current and future perspectives on the management of polypharmacy
por: Molokhia, Mariam, et al.
Publicado: (2017)

Cannabis-Responsive Biomarkers: A Pharmacometabolomics-Based Application to Evaluate the Impact of Medical Cannabis Treatment on Children with Autism Spectrum Disorder
por: Siani-Rose, Michael, et al.
Publicado: (2023)

Improving utilization of and retention in PMTCT services: Can behavioral economics help?
por: Taylor, Nicholas Kenji, et al.
Publicado: (2013)

Evidence-based ethics? On evidence-based practice and the "empirical turn" from normative bioethics
por: Goldenberg, Maya J
Publicado: (2005)

How to proceed when evidence-based practice is required but very little evidence available?
por: Leboeuf-Yde, Charlotte, et al.
Publicado: (2013)

CON: Procalcitonin does not have clinical utility in children with community-acquired pneumonia
por: Banerjee, Ritu
Publicado: (2021)

Use of the evidence base in substance abuse treatment programs for American Indians and Alaska natives: pursuing quality in the crucible of practice and policy
por: Novins, Douglas K, et al.
Publicado: (2011)

Current anti-doping policy: a critical appraisal
por: Kayser, Bengt, et al.
Publicado: (2007)

Current sample size conventions: Flaws, harms, and alternatives
por: Bacchetti, Peter
Publicado: (2010)

Is it still current to talk about first ray hypermobility?
por: Umberto, Alfieri Montrasio, et al.
Publicado: (2019)

Current clinical management of constitutional delay of growth and puberty
por: Gaudino, Rossella, et al.
Publicado: (2022)

Sicily statement on evidence-based practice
por: Dawes, Martin, et al.
Publicado: (2005)

The importance of values in evidence-based medicine
por: Kelly, Michael P., et al.
Publicado: (2015)

Revisiting concepts of evidence in implementation science
por: Brownson, Ross C., et al.
Publicado: (2022)

The economics of adaptations to evidence-based practices
por: Salloum, Ramzi G., et al.
Publicado: (2022)

Introducing an interactional approach to exploring facilitation as an implementation intervention: examining the utility of Conversation Analysis
por: Hunter, Sarah C., et al.
Publicado: (2020)

Where there is no evidence: use of expert consensus methods to fill the evidence gap in low-income countries and cultural minorities
por: Minas, Harry, et al.
Publicado: (2010)

What kind of evidence is it that Evidence-Based Medicine advocates want health care providers and consumers to pay attention to?
por: Haynes, R Brian
Publicado: (2002)

Neuroregeneration in neurodegenerative disorders
por: Enciu, Ana M, et al.
Publicado: (2011)

Dying too soon or living too long? Withdrawing treatment from patients with prolonged disorders of consciousness after Re Y
por: Huxtable, Richard
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_l3f993ljukjtfejut0fjd5i0g8